APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nanobody Discovery Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nanobody Discovery Service Market Analysis and Forecast 2026-2032

4 March 2026199 pages

Choose your research edition.

Industry ResearchNanobody Discovery Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanobody Discovery Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Nanobody Discovery Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanobody Discovery Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanobody Discovery Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Nanobody Discovery Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nanobody Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nanobody Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nanobody Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nanobody Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nanobody Discovery Service include Creative Biolabs, Curia, Sanofi, NanoTag Biotechnologies, Shanghai Medicilon Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Yeasen Biotechnology（Shanghai）Co.,Ltd., Fortis Life Sciences and Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nanobody Discovery Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nanobody Discovery Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Nanobody Discovery Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nanobody Discovery Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nanobody Discovery Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nanobody Discovery Service revenue, projected growth trends, production technology, application and end-user industry.

Nanobody Discovery Service Segment by Company

Creative Biolabs

Curia

Sanofi

NanoTag Biotechnologies

Shanghai Medicilon Inc.

Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.

Yeasen Biotechnology（Shanghai）Co.,Ltd.

Fortis Life Sciences

Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.

Biointron Biological Inc.

SAFE Pharmaceutical Technology Co., Ltd.

Abterra Biosciences

Chengdu Apak Biotechnology Co., Ltd.

ICarTab Biomedical Co., Ltd.

Wuhan Daian Biotech Ltd

Nanobody Discovery Service Segment by Type

Screening and Development Services

Engineering and Optimization Services

Production and Expression Services

Other Services

Nanobody Discovery Service Segment by Application

Drug Discovery

Biological Engineering

Clinical Diagnosis

Immune Research

Others

Nanobody Discovery Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanobody Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanobody Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanobody Discovery Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nanobody Discovery Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nanobody Discovery Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanobody Discovery Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nanobody Discovery Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Screening and Development Services Major Player Table 3. Engineering and Optimization Services Major Player Table 4. Production and Expression Services Major Player Table 5. Other Services Major Player Table 6. Global Nanobody Discovery Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Drug Discovery Major Player Table 8. Biological Engineering Major Player Table 9. Clinical Diagnosis Major Player Table 10. Immune Research Major Player Table 11. Others Major Player Table 12. Nanobody Discovery Service Industry Trends Table 13. Nanobody Discovery Service Industry Drivers Table 14. Nanobody Discovery Service Industry Opportunities and Challenges Table 15. Nanobody Discovery Service Industry Restraints Table 16. Global Nanobody Discovery Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Nanobody Discovery Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Nanobody Discovery Service Market Share by Region (2021-2026) Table 19. Global Nanobody Discovery Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Nanobody Discovery Service Market Share by Region (2027-2032) Table 21. Global Nanobody Discovery Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Nanobody Discovery Service Revenue Market Share by Players (2021-2026) Table 23. Global Nanobody Discovery Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Nanobody Discovery Service Key Players Headquarters & Area Served Table 25. Global Nanobody Discovery Service Players, Product Type & Application Table 26. Global Nanobody Discovery Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Nanobody Discovery Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Nanobody Discovery Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Nanobody Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Nanobody Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Nanobody Discovery Service Revenue Market Share by Type (2021-2026) Table 33. Global Nanobody Discovery Service Revenue Market Share by Type (2027-2032) Table 34. Global Nanobody Discovery Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nanobody Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Nanobody Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Nanobody Discovery Service Revenue Market Share by Application (2021-2026) Table 38. Global Nanobody Discovery Service Revenue Market Share by Application (2027-2032) Table 39. Creative Biolabs Company Information Table 40. Creative Biolabs Business Overview Table 41. Creative Biolabs Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Creative Biolabs Nanobody Discovery Service Product Portfolio Table 43. Creative Biolabs Recent Development Table 44. Curia Company Information Table 45. Curia Business Overview Table 46. Curia Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Curia Nanobody Discovery Service Product Portfolio Table 48. Curia Recent Development Table 49. Sanofi Company Information Table 50. Sanofi Business Overview Table 51. Sanofi Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Sanofi Nanobody Discovery Service Product Portfolio Table 53. Sanofi Recent Development Table 54. NanoTag Biotechnologies Company Information Table 55. NanoTag Biotechnologies Business Overview Table 56. NanoTag Biotechnologies Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. NanoTag Biotechnologies Nanobody Discovery Service Product Portfolio Table 58. NanoTag Biotechnologies Recent Development Table 59. Shanghai Medicilon Inc. Company Information Table 60. Shanghai Medicilon Inc. Business Overview Table 61. Shanghai Medicilon Inc. Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Shanghai Medicilon Inc. Nanobody Discovery Service Product Portfolio Table 63. Shanghai Medicilon Inc. Recent Development Table 64. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information Table 65. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview Table 66. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio Table 68. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Development Table 69. Yeasen Biotechnology（Shanghai）Co.,Ltd. Company Information Table 70. Yeasen Biotechnology（Shanghai）Co.,Ltd. Business Overview Table 71. Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Product Portfolio Table 73. Yeasen Biotechnology（Shanghai）Co.,Ltd. Recent Development Table 74. Fortis Life Sciences Company Information Table 75. Fortis Life Sciences Business Overview Table 76. Fortis Life Sciences Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Fortis Life Sciences Nanobody Discovery Service Product Portfolio Table 78. Fortis Life Sciences Recent Development Table 79. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information Table 80. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview Table 81. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio Table 83. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Development Table 84. Biointron Biological Inc. Company Information Table 85. Biointron Biological Inc. Business Overview Table 86. Biointron Biological Inc. Nanobody Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Biointron Biological Inc. Nanobody Discovery Service Product Portfolio Table 88. Biointron Biological Inc. Recent Development Table 89. SAFE Pharmaceutical Technology Co., Ltd. Company Information Table 90. SAFE Pharmaceutical Technology Co., Ltd. Business Overview Table 91. SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product Portfolio Table 93. SAFE Pharmaceutical Technology Co., Ltd. Recent Development Table 94. Abterra Biosciences Company Information Table 95. Abterra Biosciences Business Overview Table 96. Abterra Biosciences Nanobody Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Abterra Biosciences Nanobody Discovery Service Product Portfolio Table 98. Abterra Biosciences Recent Development Table 99. Chengdu Apak Biotechnology Co., Ltd. Company Information Table 100. Chengdu Apak Biotechnology Co., Ltd. Business Overview Table 101. Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product Portfolio Table 103. Chengdu Apak Biotechnology Co., Ltd. Recent Development Table 104. ICarTab Biomedical Co., Ltd. Company Information Table 105. ICarTab Biomedical Co., Ltd. Business Overview Table 106. ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product Portfolio Table 108. ICarTab Biomedical Co., Ltd. Recent Development Table 109. Wuhan Daian Biotech Ltd Company Information Table 110. Wuhan Daian Biotech Ltd Business Overview Table 111. Wuhan Daian Biotech Ltd Nanobody Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Wuhan Daian Biotech Ltd Nanobody Discovery Service Product Portfolio Table 113. Wuhan Daian Biotech Ltd Recent Development Table 114. North America Nanobody Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Nanobody Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Nanobody Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 117. North America Nanobody Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 118. North America Nanobody Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Nanobody Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 120. North America Nanobody Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 121. Europe Nanobody Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Nanobody Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Nanobody Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Nanobody Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Nanobody Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Nanobody Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 127. Europe Nanobody Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 128. China Nanobody Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 129. China Nanobody Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 130. China Nanobody Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 131. China Nanobody Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Nanobody Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Nanobody Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Nanobody Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Nanobody Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Nanobody Discovery Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Nanobody Discovery Service Revenue by Region (US$ Million) & (2021-2026) Table 138. Asia Nanobody Discovery Service Revenue by Region (US$ Million) & (2027-2032) Table 139. SAMEA Nanobody Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 140. SAMEA Nanobody Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 141. SAMEA Nanobody Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 142. SAMEA Nanobody Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 143. SAMEA Nanobody Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. SAMEA Nanobody Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 145. SAMEA Nanobody Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Nanobody Discovery Service Image Figure 2. Global Nanobody Discovery Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanobody Discovery Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Screening and Development Services Image Figure 5. Engineering and Optimization Services Image Figure 6. Production and Expression Services Image Figure 7. Other Services Image Figure 8. Global Nanobody Discovery Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Nanobody Discovery Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Drug Discovery Image Figure 11. Biological Engineering Image Figure 12. Clinical Diagnosis Image Figure 13. Immune Research Image Figure 14. Others Image Figure 15. Global Nanobody Discovery Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Nanobody Discovery Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Nanobody Discovery Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Nanobody Discovery Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Nanobody Discovery Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nanobody Discovery Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Nanobody Discovery Service Revenue Market Share by Type (2021-2032) Figure 23. Global Nanobody Discovery Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nanobody Discovery Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Nanobody Discovery Service Revenue Market Share by Application (2021-2032) Figure 26. North America Nanobody Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Nanobody Discovery Service Revenue Share by Type (2021-2032) Figure 28. North America Nanobody Discovery Service Revenue Share by Application (2021-2032) Figure 29. North America Nanobody Discovery Service Revenue Share by Country (2021-2032) Figure 30. United States Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Nanobody Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Nanobody Discovery Service Revenue Share by Type (2021-2032) Figure 35. Europe Nanobody Discovery Service Revenue Share by Application (2021-2032) Figure 36. Europe Nanobody Discovery Service Revenue Share by Country (2021-2032) Figure 37. Germany Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Nanobody Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Nanobody Discovery Service Revenue Share by Type (2021-2032) Figure 47. China Nanobody Discovery Service Revenue Share by Application (2021-2032) Figure 48. Asia Nanobody Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Nanobody Discovery Service Revenue Share by Type (2021-2032) Figure 50. Asia Nanobody Discovery Service Revenue Share by Application (2021-2032) Figure 51. Asia Nanobody Discovery Service Revenue Share by Region (2021-2032) Figure 52. Japan Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Nanobody Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Nanobody Discovery Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Nanobody Discovery Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Nanobody Discovery Service Revenue Share by Country (2021-2032) Figure 62. Brazil Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Nanobody Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Screening and Development Services
  • Engineering and Optimization Services
  • Production and Expression Services
  • Other Services
Applications
  • Drug Discovery
  • Biological Engineering
  • Clinical Diagnosis
  • Immune Research
  • Others
Companies covered
  • Creative Biolabs
  • Curia
  • Sanofi
  • NanoTag Biotechnologies
  • Shanghai Medicilon Inc.
  • Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  • Yeasen Biotechnology（Shanghai）Co.,Ltd.
  • Fortis Life Sciences
  • Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  • Biointron Biological Inc.
  • SAFE Pharmaceutical Technology Co., Ltd.
  • Abterra Biosciences
  • Chengdu Apak Biotechnology Co., Ltd.
  • ICarTab Biomedical Co., Ltd.
  • Wuhan Daian Biotech Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nanobody Discovery Service Market by Type
  3. 1.2.1 Global Nanobody Discovery Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Screening and Development Services
  5. 1.2.3 Engineering and Optimization Services
  6. 1.2.4 Production and Expression Services
  7. 1.2.5 Other Services
  8. 1.3 Nanobody Discovery Service Market by Application
  9. 1.3.1 Global Nanobody Discovery Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Drug Discovery
  11. 1.3.3 Biological Engineering
  12. 1.3.4 Clinical Diagnosis
  13. 1.3.5 Immune Research
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Nanobody Discovery Service Market Dynamics
  1. 2.1 Nanobody Discovery Service Industry Trends
  2. 2.2 Nanobody Discovery Service Industry Drivers
  3. 2.3 Nanobody Discovery Service Industry Opportunities and Challenges
  4. 2.4 Nanobody Discovery Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nanobody Discovery Service Market Perspective (2021-2032)
  2. 3.2 Global Nanobody Discovery Service Growth Trends by Region
  3. 3.2.1 Global Nanobody Discovery Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nanobody Discovery Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Nanobody Discovery Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nanobody Discovery Service Revenue by Players
  2. 4.1.1 Global Nanobody Discovery Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Nanobody Discovery Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nanobody Discovery Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nanobody Discovery Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nanobody Discovery Service Key Players Headquarters & Area Served
  7. 4.4 Global Nanobody Discovery Service Players, Product Type & Application
  8. 4.5 Global Nanobody Discovery Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nanobody Discovery Service Market CR5 and HHI
  11. 4.6.3 2025 Nanobody Discovery Service Tier 1, Tier 2, and Tier 3
5 Nanobody Discovery Service Market Size by Type
  1. 5.1 Global Nanobody Discovery Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nanobody Discovery Service Revenue by Type (2021-2032)
  3. 5.3 Global Nanobody Discovery Service Revenue Market Share by Type (2021-2032)
6 Nanobody Discovery Service Market Size by Application
  1. 6.1 Global Nanobody Discovery Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nanobody Discovery Service Revenue by Application (2021-2032)
  3. 6.3 Global Nanobody Discovery Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Creative Biolabs
  2. 7.1.1 Creative Biolabs Company Information
  3. 7.1.2 Creative Biolabs Business Overview
  4. 7.1.3 Creative Biolabs Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Creative Biolabs Nanobody Discovery Service Product Portfolio
  6. 7.1.5 Creative Biolabs Recent Developments
  7. 7.2 Curia
  8. 7.2.1 Curia Company Information
  9. 7.2.2 Curia Business Overview
  10. 7.2.3 Curia Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Curia Nanobody Discovery Service Product Portfolio
  12. 7.2.5 Curia Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Nanobody Discovery Service Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 NanoTag Biotechnologies
  20. 7.4.1 NanoTag Biotechnologies Company Information
  21. 7.4.2 NanoTag Biotechnologies Business Overview
  22. 7.4.3 NanoTag Biotechnologies Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 NanoTag Biotechnologies Nanobody Discovery Service Product Portfolio
  24. 7.4.5 NanoTag Biotechnologies Recent Developments
  25. 7.5 Shanghai Medicilon Inc.
  26. 7.5.1 Shanghai Medicilon Inc. Company Information
  27. 7.5.2 Shanghai Medicilon Inc. Business Overview
  28. 7.5.3 Shanghai Medicilon Inc. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Shanghai Medicilon Inc. Nanobody Discovery Service Product Portfolio
  30. 7.5.5 Shanghai Medicilon Inc. Recent Developments
  31. 7.6 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  32. 7.6.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
  33. 7.6.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
  34. 7.6.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio
  36. 7.6.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
  37. 7.7 Yeasen Biotechnology（Shanghai）Co.,Ltd.
  38. 7.7.1 Yeasen Biotechnology（Shanghai）Co.,Ltd. Company Information
  39. 7.7.2 Yeasen Biotechnology（Shanghai）Co.,Ltd. Business Overview
  40. 7.7.3 Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Product Portfolio
  42. 7.7.5 Yeasen Biotechnology（Shanghai）Co.,Ltd. Recent Developments
  43. 7.8 Fortis Life Sciences
  44. 7.8.1 Fortis Life Sciences Company Information
  45. 7.8.2 Fortis Life Sciences Business Overview
  46. 7.8.3 Fortis Life Sciences Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Fortis Life Sciences Nanobody Discovery Service Product Portfolio
  48. 7.8.5 Fortis Life Sciences Recent Developments
  49. 7.9 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  50. 7.9.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
  51. 7.9.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
  52. 7.9.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio
  54. 7.9.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
  55. 7.10 Biointron Biological Inc.
  56. 7.10.1 Biointron Biological Inc. Company Information
  57. 7.10.2 Biointron Biological Inc. Business Overview
  58. 7.10.3 Biointron Biological Inc. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Biointron Biological Inc. Nanobody Discovery Service Product Portfolio
  60. 7.10.5 Biointron Biological Inc. Recent Developments
  61. 7.11 SAFE Pharmaceutical Technology Co., Ltd.
  62. 7.11.1 SAFE Pharmaceutical Technology Co., Ltd. Company Information
  63. 7.11.2 SAFE Pharmaceutical Technology Co., Ltd. Business Overview
  64. 7.11.3 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product Portfolio
  66. 7.11.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Developments
  67. 7.12 Abterra Biosciences
  68. 7.12.1 Abterra Biosciences Company Information
  69. 7.12.2 Abterra Biosciences Business Overview
  70. 7.12.3 Abterra Biosciences Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Abterra Biosciences Nanobody Discovery Service Product Portfolio
  72. 7.12.5 Abterra Biosciences Recent Developments
  73. 7.13 Chengdu Apak Biotechnology Co., Ltd.
  74. 7.13.1 Chengdu Apak Biotechnology Co., Ltd. Company Information
  75. 7.13.2 Chengdu Apak Biotechnology Co., Ltd. Business Overview
  76. 7.13.3 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product Portfolio
  78. 7.13.5 Chengdu Apak Biotechnology Co., Ltd. Recent Developments
  79. 7.14 ICarTab Biomedical Co., Ltd.
  80. 7.14.1 ICarTab Biomedical Co., Ltd. Company Information
  81. 7.14.2 ICarTab Biomedical Co., Ltd. Business Overview
  82. 7.14.3 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product Portfolio
  84. 7.14.5 ICarTab Biomedical Co., Ltd. Recent Developments
  85. 7.15 Wuhan Daian Biotech Ltd
  86. 7.15.1 Wuhan Daian Biotech Ltd Company Information
  87. 7.15.2 Wuhan Daian Biotech Ltd Business Overview
  88. 7.15.3 Wuhan Daian Biotech Ltd Nanobody Discovery Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Wuhan Daian Biotech Ltd Nanobody Discovery Service Product Portfolio
  90. 7.15.5 Wuhan Daian Biotech Ltd Recent Developments
8 North America
  1. 8.1 North America Nanobody Discovery Service Revenue (2021-2032)
  2. 8.2 North America Nanobody Discovery Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Nanobody Discovery Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Nanobody Discovery Service Revenue by Type (2027-2032)
  5. 8.3 North America Nanobody Discovery Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Nanobody Discovery Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Nanobody Discovery Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Nanobody Discovery Service Revenue by Application (2027-2032)
  9. 8.5 North America Nanobody Discovery Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Nanobody Discovery Service Revenue by Country
  11. 8.6.1 North America Nanobody Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nanobody Discovery Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Nanobody Discovery Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nanobody Discovery Service Revenue (2021-2032)
  2. 9.2 Europe Nanobody Discovery Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nanobody Discovery Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nanobody Discovery Service Revenue by Type (2027-2032)
  5. 9.3 Europe Nanobody Discovery Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nanobody Discovery Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nanobody Discovery Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nanobody Discovery Service Revenue by Application (2027-2032)
  9. 9.5 Europe Nanobody Discovery Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nanobody Discovery Service Revenue by Country
  11. 9.6.1 Europe Nanobody Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nanobody Discovery Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nanobody Discovery Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nanobody Discovery Service Revenue (2021-2032)
  2. 10.2 China Nanobody Discovery Service Revenue by Type (2021-2032)
  3. 10.2.1 China Nanobody Discovery Service Revenue by Type (2021-2026)
  4. 10.2.2 China Nanobody Discovery Service Revenue by Type (2027-2032)
  5. 10.3 China Nanobody Discovery Service Revenue Share by Type (2021-2032)
  6. 10.4 China Nanobody Discovery Service Revenue by Application (2021-2032)
  7. 10.4.1 China Nanobody Discovery Service Revenue by Application (2021-2026)
  8. 10.4.2 China Nanobody Discovery Service Revenue by Application (2027-2032)
  9. 10.5 China Nanobody Discovery Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nanobody Discovery Service Revenue (2021-2032)
  2. 11.2 Asia Nanobody Discovery Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nanobody Discovery Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nanobody Discovery Service Revenue by Type (2027-2032)
  5. 11.3 Asia Nanobody Discovery Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nanobody Discovery Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nanobody Discovery Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nanobody Discovery Service Revenue by Application (2027-2032)
  9. 11.5 Asia Nanobody Discovery Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nanobody Discovery Service Revenue by Country
  11. 11.6.1 Asia Nanobody Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nanobody Discovery Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nanobody Discovery Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nanobody Discovery Service Revenue (2021-2032)
  2. 12.2 SAMEA Nanobody Discovery Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nanobody Discovery Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nanobody Discovery Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nanobody Discovery Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nanobody Discovery Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nanobody Discovery Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nanobody Discovery Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nanobody Discovery Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nanobody Discovery Service Revenue by Country
  11. 12.6.1 SAMEA Nanobody Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nanobody Discovery Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nanobody Discovery Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst